Loading...

Purified anti-mouse CD3ε Antibody

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
145-2C11_Pure_021606
C57BL/6 mouse splenocytes were stained with purified CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by anti-Armenian hamster IgG FITC.
  • 145-2C11_Pure_021606
    C57BL/6 mouse splenocytes were stained with purified CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by anti-Armenian hamster IgG FITC.
  • 145-2C11_PURE_CD3e_Antibody_IHC-F_033017
    C57BL/6 mouse frozen spleen section was fixed with 4% paraformaldehyde (PFA) for ten minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then the section was stained with 10 µg/mL of purified anti-mouse CD3ε (clone 145-2C11) and 10 µg/mL of Alexa Fluor® 488 anti-mouse/human CD45R/B220 (clone RA3-6B2) (green) overnight at 4°C, followed by 2.5 µg/mL of Alexa Fluor® 594 Goat anti-hamster (Armenian) IgG (clone Poly4055) (red) for two hours at room temperature. The image was captured by 10X objective.
  • 145-2C11_PURE_CD3e_Antibody_IHC-F_2_102518
    Fresh, frozen mouse spleen was stained with purified CD3ε clone 145-2C11 conjugated and detected with a Cy3 CODEX™ oligonucleotide duplex (red). Samples were counterstained with B220 A647 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
100301 50 µg $24
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100302 500 µg $72
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The CD3ε antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F - Verified
IP, Activ, Block, WB, ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per million cells in 100 µl volume. For immunohistochemical staining on frozen tissue sections, the suggested use of this reagent is 5.0 - 10 µg per ml. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed
  2. Chemnitz J, et al. 2019. Sci Rep. 3.745138889. PubMed
  3. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  4. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  5. Kim K, et al. 2016. PLoS One. 11: 0148576. PubMed
  6. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  7. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  8. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  9. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  10. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  11. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  12. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  13. Zhang J, et al. 2023. Int J Nanomedicine. 18:209. PubMed
  14. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  15. Schick J, et al. 2023. Elife. 12: . PubMed
  16. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  17. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  18. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  19. Akiyama C, et al. 2019. J Immunol. 203:835. PubMed
  20. Bergfeld A, et al. 2017. Front Microbiol. 0.919444444. PubMed
  21. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  22. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  23. Tian J, et al. 2021. Autophagy. 17:2586. PubMed
  24. Tersteegen A, et al. 2021. Infect Immun. 89:. PubMed
  25. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  26. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  27. Biljes D, et al. 2017. EXCLI J. 0.86875. PubMed
  28. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  29. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  30. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  31. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  32. Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
  33. Namavari A, et al. 2012. Invest Ophthalmol Vis Sci . 53:4575. PubMed
  34. Goel S, et al. 2017. Nature. 548:471. PubMed
  35. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  36. McLane LM, et al. 2021. Cell Reports. 35(6):109120. PubMed
  37. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  38. Sanctuary MR, et al. 2019. Mucosal Immunol. 0.638888889. PubMed
  39. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  40. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  41. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  42. Crawford G, et al. 2018. Nat Immunol. 1.388194444. PubMed
  43. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  44. Oghumu S, et al. 2019. J Immunol. 203:789. PubMed
  45. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  46. Jennings EK, et al. 2021. STAR Protocols. 2(1):100284. PubMed
  47. Lu SX, et al. 2021. Cell. . PubMed
  48. Liu W, et al. 2021. Stem Cell Res Ther. 12:153. PubMed
  49. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  50. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  51. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  52. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  53. Willimsky G, et al. 2021. Elife. 10:. PubMed
  54. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  55. Muhammad F, et al. 2020. Front Immunol. 975:11. PubMed
  56. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  57. Edenborough KM, et al. 2019. Front Immunol. 10:2414. PubMed
  58. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  59. Robert S, et al. 2018. Bone Marrow Transplant. 53:807. PubMed
  60. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  61. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  62. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  63. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  64. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  65. El Maï M, et al. 2021. Cancers (Basel). 13:. PubMed
  66. Rao TN, et al. 2020. J Immunol. 204:2600. PubMed
  67. Perchonock C, et al. 2006. Mol Cell Biol . 26:6005. PubMed
  68. Guo Y, et al. 2008. Blood. 112:480. PubMed
  69. Sekiya T et al. 2018. Cell reports. 24(6):1627-1638 . PubMed
  70. Lyon de Ana C, et al. 2019. J Immunol. 202:1112. PubMed
  71. Wu P et al. 2019. Molecular cell. 73(5):1015-1027 . PubMed
  72. Tuzlak S, et al. 2017. Cell Death Differ. 24:523. PubMed
  73. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  74. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  75. Mullins GN, et al. 2020. Sci Rep. 10:21994. PubMed
  76. Hilligan KL, et al. 2020. Nat Commun. 11:5637. PubMed
  77. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  78. Hanoteau A, et al. 2019. J Immunother Cancer. 7:10. PubMed
  79. Zhang P, et al. 2022. BMC Med. 20:435. PubMed
  80. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  81. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  82. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  83. Cain MP, et al. 2020. Dis Model Mech. 13:00. PubMed
  84. Takushi SE, et al. 2020. Hum Gene Ther. 31:626. PubMed
  85. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  86. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  87. McCully M, et al. 2015. J Immunol. 195: 96 - 104. PubMed
  88. Bremser A, et al. 2015. PLoS One. 10: 0137393. PubMed
  89. Chen Z et al. 2019. Immunity. 51(5):840-855 . PubMed
  90. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  91. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  92. Reed J, et al. 2020. Bio Protoc. 10:e3607. PubMed
  93. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  94. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  95. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  96. Borges TJ, et al. 2018. Nat Commun. 9:3482. PubMed
  97. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  98. Hsieh WC, et al. 2020. JCI Insight. 5:00. PubMed
  99. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  100. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  101. Du J, et al. 2018. AMB Express. 8:158. PubMed
  102. Majer O, et al. 2019. Nature. 575:366. PubMed
  103. Won HY, et al. 2017. Sci Rep. 7:16946. PubMed
  104. Van De Velde LA, et al. 2017. J Biol Chem. 292:15:00. PubMed
  105. Scholz T, et al. 2017. PLoS One. 12:e0182646. PubMed
  106. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  107. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  108. Sun L, et al. 2022. Front Immunol. 13:823853. PubMed
  109. Wu G, et al. 2022. Wellcome Open Res. 6:134. PubMed
  110. Otsuka S, et al. 2021. J Clin Invest. 131:. PubMed
  111. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  112. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  113. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  114. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  115. Seo N, et al. 2018. Nat Commun. 9:435. PubMed
  116. Parzmair GP, et al. 2017. J Leukoc Biol. 101:407. PubMed
  117. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  118. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  119. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  120. Hao Y, et al. 2018. Front Immunol. 9:1127. PubMed
  121. Ma VP, et al. 2022. Sci Adv. 8:eabg4485. PubMed
  122. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  123. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  124. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  125. Sripada A, et al. 2021. PLoS Biol. 19:e3001063. PubMed
  126. Klein JC, et al. 2017. Nat Commun. 8:14600. PubMed
  127. Sandy A, et al. 2013. J Immunol. 190:5818. PubMed
  128. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  129. Katagiri T, et al. 2019. Mucosal Immunol. 12:p1104. PubMed
  130. Wang HC, et al. 2017. J Immunol. 198:3149. PubMed
  131. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  132. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  133. Wu Y, et al. 2021. J Clin Invest. 131:. PubMed
  134. Rigo MM, et al. 2020. FEBS J. :. PubMed
  135. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  136. Spranger S, et al. 2017. Cancer Cell. 31:711. PubMed
  137. Wang W, et al. 2018. J Vasc Surg. 68:1538. PubMed
  138. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  139. Lee J, et al. 2020. Cells. 9:. PubMed
  140. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  141. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  142. Teijeira A, et al. 2018. Cancer Immunol Res. 6:798. PubMed
  143. Jiao S, et al. 2020. Cell. 179(5):1177-1190.e13.. PubMed
  144. Link MA, et al. 2017. PLoS One. 12:e0184320. PubMed
  145. Aguilar OA, et al. 2020. J Immunol. 205:1709. PubMed
  146. Taylor MD, et al. 2020. Front Immunol. 11:1946. PubMed
  147. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  148. Yoon S, et al. 2022. Nat Commun. 13:1602. PubMed
  149. Chen Z, et al. 2021. Cell. 184(5):1262-1280.e22. PubMed
  150. Gaspar M, et al. 2020. Cancer Immunol Res. 0.875694444. PubMed
  151. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  152. Koch K, et al. 2022. Int J Mol Sci. 23:. PubMed
  153. Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed
  154. Cui X, et al. 2017. J Immunol. 199:4066. PubMed
  155. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  156. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  157. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  158. Yang H, et al. 2022. Cell Death Discov. 8:183. PubMed
  159. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  160. Sun Y, et al. 2021. Nat Commun. 12:5147. PubMed
  161. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  162. Afzali B, et al. 2017. Nat Immunol. 18:813. PubMed
  163. Cohen MA, et al. 2020. Cell Stem Cell. 26(4):579-592. PubMed
  164. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  165. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  166. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  167. Dey P, et al. 2020. Cancer Discov. 10:608. PubMed
  168. Perchonock C, et al. 2007. J Immunol. 179:1768. PubMed
  169. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  170. Abe Y, et al. 2017. Biochem Biophys Rep. 0.543055556. PubMed
  171. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  172. Lin J, et al. 2017. Nat Commun. . 10.1038/s41467-017-01477-5. PubMed
  173. Taylor MD, et al. 2020. Front Immunol. 11:563402. PubMed
  174. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  175. Sasai M, et al. 2021. J Exp Med. 218:. PubMed
  176. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  177. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  178. Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
  179. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  180. Wang G, et al. 2015. PLoS One. 10:121968. PubMed
  181. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  182. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  183. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  184. Akkaya B, et al. 2018. J Immunol. 201:3294. PubMed
  185. Bordoloi D, et al. 2021. Genes Cancer. 12:51. PubMed
  186. Wang W, et al. 2022. Nat Commun. 13:4495. PubMed
  187. Xia L, et al. 2021. Cancer Immunol Res. 9:707. PubMed
  188. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  189. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  190. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  191. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  192. Yamazaki K, et al. 2022. Sci Rep. 12:3242. PubMed
  193. Chen YH, et al. 2022. Arthritis Res Ther. 24:27. PubMed
  194. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
RRID
AB_312666 (BioLegend Cat. No. 100301)
AB_312667 (BioLegend Cat. No. 100302)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3ε Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse CD3ε 145-2C11 FC
PE/Dazzle™ 594 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε (Maxpar® Ready) 145-2C11 FC,CyTOF®
Brilliant Violet 510™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 711™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 785™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 605™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 750 anti-mouse CD3ε 145-2C11 FC
GoInVivo™ Purified anti-mouse CD3ε 145-2C11 FC
APC anti-mouse CD3ε 145-2C11 FC
Biotin anti-mouse CD3ε 145-2C11 FC,IHC-F
FITC anti-mouse CD3ε 145-2C11 FC
PE anti-mouse CD3ε 145-2C11 FC
PE/Cyanine5 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Alexa Fluor® 488 anti-mouse CD3ε 145-2C11 FC
Alexa Fluor® 647 anti-mouse CD3ε 145-2C11 FC,IHC-F,3D IHC
PerCP anti-mouse CD3ε 145-2C11 FC
PerCP/Cyanine5.5 anti-mouse CD3ε 145-2C11 FC
APC/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Pacific Blue™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 421™ anti-mouse CD3ε 145-2C11 FC,ICC
Ultra-LEAF™ Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Spark YG™ 593 anti-mouse CD3 145-2C11 FC
PerCP/Fire™ 780 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 650™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 750™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 810 anti-mouse CD3ε Antibody 145-2C11 FC
Spark YG™ 581 anti-mouse CD3ε (Flexi-Fluor™) 145-2C11 FC
Spark NIR™ 685 anti-mouse CD3ε (Flexi-Fluor™) Antibody 145-2C11 FC
Go To Top Version: 2    Revision Date: 10/17/2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account